Precision System Science Co.,Ltd (JP:7707)
:7707
Want to see JP:7707 full AI Analyst Report?
Top Page
Precision System Science Co.,Ltd
(7707)
Select Model
Select Model
Rating:45Neutral
Price Target:
¥219.00
▲(17.74% Upside)
Action:ReiteratedDate:10/02/25
The overall stock score of 45 reflects significant challenges in financial performance, particularly in profitability and cash flow management. Technical analysis indicates weak momentum, and valuation metrics are unattractive due to negative earnings. These factors collectively result in a low score, highlighting the need for substantial improvements in operational efficiency and financial health.
Positive Factors
Revenue recovery
A >20% revenue growth figure signals a meaningful recovery in demand and expanding market traction for the company's automation equipment. Sustained top-line growth provides a platform to leverage fixed costs, support R&D and service expansion, and improve long-term operating leverage.
Negative Factors
Persistent negative profitability
Consistently negative net margins indicate the company struggles to convert sales into earnings due to cost structure or pricing pressure. Persistent losses erode retained earnings, limit ability to self-fund growth and make long-term investment and hiring decisions more constrained without profitability improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue recovery
A >20% revenue growth figure signals a meaningful recovery in demand and expanding market traction for the company's automation equipment. Sustained top-line growth provides a platform to leverage fixed costs, support R&D and service expansion, and improve long-term operating leverage.
Read all positive factors
Precision System Science Co.,Ltd (7707) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.06B
Dividend YieldN/A
Average Volume (3M)159.67K
Price to Earnings (P/E)169.3
Beta (1Y)1.32
Revenue Growth17.91%
EPS Growth77.32%
CountryJP
Employees158
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,666,900
10 Day Avg. Volume171,040
30 Day Avg. Volume159,673
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)1.46
Price to Sales (P/S)1.17
P/FCF Ratio127.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Precision System Science Co.,Ltd Business Overview & Revenue Model
Company Description
Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally. The company manufact...
How the Company Makes Money
null...
Precision System Science Co.,Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
50
Neutral
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.69B | 3.98B | 5.28B | 7.43B | 9.30B |
| Gross Profit | 1.38B | 950.38M | 1.35B | 2.49B | 3.10B |
| EBITDA | 10.06M | -661.75M | -594.05M | 740.33M | 1.16B |
| Net Income | -253.10M | -1.12B | -1.32B | 45.34M | 795.99M |
Balance Sheet | |||||
| Total Assets | 4.94B | 6.40B | 9.76B | 11.41B | 11.57B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 1.92B | 2.45B | 2.76B | 4.04B |
| Total Debt | 564.21M | 1.37B | 3.88B | 4.03B | 3.69B |
| Total Liabilities | 1.18B | 2.25B | 4.54B | 4.90B | 4.99B |
| Stockholders Equity | 3.76B | 4.14B | 5.22B | 6.51B | 6.58B |
Cash Flow | |||||
| Free Cash Flow | 43.24M | -130.81M | -162.03M | -1.38B | -2.09B |
| Operating Cash Flow | 95.83M | -106.80M | -6.75M | 869.16M | -280.97M |
| Investing Cash Flow | -8.24M | 2.06B | -213.70M | -2.29B | -1.81B |
| Financing Cash Flow | -910.82M | -2.51B | -154.05M | 93.73M | 4.00B |
Precision System Science Co.,Ltd Technical Analysis
Positive
186.00
Price Trends
224.90
Positive
213.24
Positive
205.28
Positive
Market Momentum
-0.46
Negative
53.72
Neutral
65.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Positive. The current price of 186 is below the 20-day moving average (MA) of 216.95, below the 50-day MA of 224.90, and below the 200-day MA of 205.28, indicating a bullish trend. The MACD of -0.46 indicates Negative momentum. The RSI at 53.72 is Neutral, neither overbought nor oversold. The STOCH value of 65.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7707.
Precision System Science Co.,Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥13.57B | 41.40 | ― | ― | 12.91% | 37.96% | |
70 Outperform | ¥7.41B | 22.07 | ― | 4.57% | 6.49% | -32.16% | |
56 Neutral | ¥17.12B | 120.78 | ― | ― | 1.24% | -33.41% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥11.70B | -8.14 | ― | ― | -42.49% | -2.37% | |
48 Neutral | ¥6.27B | -6.80 | ― | ― | 56.17% | -11.63% | |
45 Neutral | ¥6.06B | 169.33 | ― | ― | 17.91% | 77.32% |
* Healthcare Sector Average
JP:7707
Precision System Science Co.,Ltd
225.00
30.00
15.38%
JP:3386
Cosmo Bio Co., Ltd.
1,296.00
210.98
19.44%
JP:4570
Immuno-Biological Laboratories Co., Ltd.
1,510.00
1,059.93
235.50%
JP:4892
Cyfuse Biomedical K.K.
630.00
-365.00
-36.68%
JP:4978
ReproCELL Inc.
180.00
31.00
20.81%
JP:7776
CellSeed Inc.
298.00
-328.00
-52.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.